Navigation Links
More evidence that melanoma does not conform to the cancer stem cell model
Date:11/15/2010

bottom of the hierarchy can't," Morrison said. However, the Morrison laboratory was unable to find any subset of melanoma cells that lacked the ability to form tumors.

"In our model, all these cells can form tumors," he said. "And they're phenotypically different from each other not because they're hierarchically organized but because they're just turning these surface markers on and off."

The U-M team found that all tumor-forming melanoma cells gave rise to progeny with a variety of marker patterns, and that all of those sub-populations retained the ability to form tumors. The marker changes appeared to be reversible, rather than being associated with a transition from tumor-forming to non-tumor-forming states, as the cancer stem cell model would predict.

The Cancer Cell paper follows up on work reported by the Morrison lab in the Dec. 4, 2008, edition of the journal Nature. The Nature article demonstrated that tumor-forming melanoma cells are not rare, as predicted by the cancer stem cell model. The researchers determined that at least one-quarter of melanoma cells have the ability to form new tumors.

Melanoma kills more than 8,000 Americans each year. The human melanoma cells used in this study were provided---with the patients' permission---from the U-M's Multidisciplinary Melanoma Program, one of the country's largest melanoma programs and part of the U-M Comprehensive Cancer Center.

"These new findings significantly advance our understanding of melanoma," said cutaneous oncologist Dr. Timothy Johnson, director of the U-M melanoma program and a co-author of the Cancer Cell paper.

"This type of groundbreaking discovery achieves our core objective of combining clinical studies with laboratory research to develop new and better treatments for optimal patient care," Johnson said.


'/>"/>

Contact: Jim Erickson
ericksn@umich.edu
734-647-1842
University of Michigan
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Evidence is weak for tropical rainforest 65 million years ago in Africas low-latitudes
2. New evidence that fat cells are not just dormant storage depots for calories
3. Oldest evidence of dinosaurs found in Polish footprints
4. Researchers find first genetic evidence for loss of teeth in the common ancestor of baleen whales
5. Marine animals suggest evidence for a trans-Antarctic seaway
6. Animal bone markings show evidence that Lucy species used stone tools, ate meat
7. Scientists discover oldest evidence of human stone tool use and meat-eating
8. Scientists find new evidence of genetically modified plants in the wild
9. Scientists find the first evidence of genetically modified plants in the wild
10. Body of evidence: New fast, reliable method to detect gravesoil
11. Lack of access to evidence-based HIV prevention and care is a fundamental violation of human rights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... Research and Markets( http://www.researchandmarkets.com/research/zj7h4f/latin_america ... America Biomedical Sensors Market - Growth, Trends & Forecasts ... Latin America Biomedical Sensors market is estimated at $0.65 ... the period 2014-2020 The near future will ... formulation of each individual. These sensors can be set ...
(Date:6/25/2015)... 25, 2015 According to ... (Swipe & Area), Technology, Material (Optical Prism, Piezoelectric, ... Security & Others) & Geography - Global Forecast ... said market is expected to reach $14,500.07 Million ... Browse 76 market Tables and 109 ...
(Date:6/25/2015)... 2015  TAKE Solutions Ltd., a global business technology ... States Patent and Trademark Office (USPTO) for its "Method ... Solutions, Clinical Accelerators to reduce the time taken to ... standardization without the accelerators), thus reducing time to market. ... At the heart of the patented Clinical Data Standardization ...
Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4TAKE Solutions Awarded Patent By USPTO 2
... AMHERST, Mass. When researchers at the University of ... the bacterium Geobacter sulfurreducens conducts ... physicists quite comfortable with the idea of such a ... "For biologists, Geobacter ,s behavior represents a ...
... (DFG, German Research Foundation) is establishing eight new Research ... its 2013 March meeting in Bonn. The research collaborations ... pressing issues in their research areas and to establish ... Units, the new units will be interdisciplinary and span ...
... in modern warfare, often resulting in severe tissue damage, ... to the new research presented today at the 2013 ... (AAOS). The Return to Run (RTR) program is ... high-level function to wounded warriors. It includes use ...
Cached Biology News:UMass Amherst researchers reveal mechanism of novel biological electron transfer 2UMass Amherst researchers reveal mechanism of novel biological electron transfer 3DFG establishes 8 new research units 2DFG establishes 8 new research units 3DFG establishes 8 new research units 4DFG establishes 8 new research units 5
(Date:7/1/2015)... HAMILTON, Bermuda , July 1, 2015 /PRNewswire/ ... biopharmaceutical company focused on the treatment of dementia, ... investor briefing on July 22 at 5:45 p.m. ... at the Alzheimer,s Association International Conference 2015 (AAIC). ... following remarks: , Dr. Lawrence ...
(Date:7/1/2015)... ... 2015 , ... A newly launched business plan contest will ask startup companies ... in life sciences R&D. The Pistoia Alliance President’s Startup Challenge 2015 will see small ... period of expert mentorship from a senior industry figure drawn from the Pistoia Alliance ...
(Date:7/1/2015)... Indianapolis, IN (PRWEB) , ... July 01, 2015 , ... ... the 2015 BIO International Convention in Philadelphia, PA. , The presentation took ... milestones and outlined the plans for the development of APX3330 for the treatment of ...
(Date:7/1/2015)...  UCB, a multinational biopharmaceutical company, and Genpact ... designing, transforming, and running intelligent business operations, have ... their close collaboration in driving transformation that achieved ... (GBS) finance organization. The Aecus Innovation ... together effectively to embrace the innovative promise of ...
Breaking Biology Technology:Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5
... Calif., May 30 AMDL, Inc. (Amex:,ADL), ... with,operations in Shenzhen, Jiangxi and Jilin, China, announced ... anti-aging line., The company is releasing the ... of AMDL,s Chinese subsidiary Jade Pharmaceutical,Inc. (JPI). Scheduled ...
... Dx(TM) Genomic Grade Could Spare Tens ... ASCO Annual Meeting, ... Ipsogen SA (Marseilles, France and New,Haven, CT, USA), a ... that it is entering the breast cancer,diagnostic market with the ...
... Phase I/II Study of Zalutumumab in, Combination With Irinotecan Chemotherapy ... ... COPENHAGEN, Denmark, May 30 Genmab A/S (OMX:,GEN) announced today ... with irinotecan chemotherapy to treat,colorectal cancer (CRC). The study will include ...
Cached Biology Technology:AMDL Announces New GOODNAK Consumer Anti-Aging Products for Use in Skin Renewal Treatments 2Ipsogen Launches MapQuant Dx(TM) Genomic Grade Test to Identify Breast Cancer Patients who Benefit From Chemotherapy 2Ipsogen Launches MapQuant Dx(TM) Genomic Grade Test to Identify Breast Cancer Patients who Benefit From Chemotherapy 3Ipsogen Launches MapQuant Dx(TM) Genomic Grade Test to Identify Breast Cancer Patients who Benefit From Chemotherapy 4Genmab Initiates Zalutumumab Combination Study in Colorectal Cancer 2Genmab Initiates Zalutumumab Combination Study in Colorectal Cancer 3
... XIII in both reduced and non-reduced forms. It ... or human Factor XII. Factor XIII is a ... two subunits. Factor XIII-A is the catalytic subunit ... XIII is present in plasma as an Alpha2Beta2 ...
... Anti-Lipid Phosphate Phosphatase 2 ... buffered aqueous solution ... saline containing 0.08% sodium ... from the human LPP2 ...
Anti-CaM kinase II recognizes the enzymes a subunit (6) and reacts with tissue from all mammalian species tested, as well as with chicken and frog tissues....
... Anti-MAPKAPK-2, Phospho-Specific(Thr 222 ) ... NaCl, 10 mM sodium HEPES, ... pH 7.5. Recognizes the ~47 ... 2 (MAPKAPK-2) protein phosphorylated at ...
Biology Products: